Type of study: meta-analysis Number of citations: 2 Year: 2022 Authors: Cheng-qiong Wang, Youming Shen, Xiao-fan Chen, Hong Jiang, Xue Yang, Teng-yang Fan, Shu-Guang Li, Ping Yang, L
The need for disease modifying treatment [Market size and Growth & Competition] The Parkinsons disease treatment market is expected to grow from USD 4.24 billion in 2017 to USD 5,694.1 million in 2022, it grows at a CAGR of 6.1%.(source: reportsnreports) Currently, 2 investigator initiated trials using GLP-1 agonists (lixisenatide and liraglutide) are recruiting PD patients in collaboration with CPT and VARI in France and US respectively, which will prove and support the efficacy of the GLP-1R pathway in PD
Alexander said he thinks obesity drugs will eventually become affordable cheap even
Diabetes & Metabolism Journal, 47 (3), 315-324
Xiao F, Chen Y, Qi J, Yao Q, Xie J, Jiang X
Current opinion in clinical nutrition and metabolic care, 26(6), 521527